Mumbai, May 14 (IANS). Consolidated net profit of Diagnostics Chain Metropolis Healthcare, led by Amira Shah, recorded a 19.96 percent decline in the fourth quarter of FY 25. Along with this, the cost of the company has also increased.
Metropolis Healthcare said in its stock exchange filing that the company’s profits in the January-March period of FY 25 have reduced to Rs 29.23 crore, which was Rs 36.52 crore in the same period last year.
However, the company’s profits have been recorded, but income has increased. In the fourth quarter of FY 25, the company’s income has increased by 4.13 percent to Rs 345.29 crore, which was at Rs 331 crore in the same period last year.
The fourth quarter of FY 25 has seen pressure on profits due to higher operating costs. The total expenditure during the March quarter increased by 11.74 percent to Rs 316.21 crore on an annual basis, which was Rs 283 crore in the same quarter of the previous financial year.
Apart from this, the cost of material consumption of the company has increased by 6.62 percent to Rs 71.53 crore in the March quarter and the employee expenditure has increased by 15.01 percent to Rs 82.19 crore.
The net profit of Metropolis Healthcare for the entire FY 25 has increased to Rs 146 crore, which was at Rs 128 crore in FY 24.
Shah, chairperson and full -time director of Metropolis Healthcare, said that the company continues to invest on its laboratory network, technology and talent.
He further said that even in the challenging environment, the company remains successful and operational proficiency in attracting customers.
Shah said that the company is focusing on its expansion in the Beetusi segment and this will help in increasing the next growth.
Metropolis Healthcare’s stock on the National Stock Exchange (NSE) fell by 5.05 percent to Rs 1,615.
— IANS
ABS /
